Merkel C, Gatta A, Zoli M, Bolognesi M, Angeli P, Iervese T, Marchesini G, Ruol A
Istituto di Medicina Clinica, Università di Padova, Italy.
Dig Dis Sci. 1991 Sep;36(9):1197-203. doi: 10.1007/BF01307508.
Seventy-eight patients with cirrhosis were prospectively followed for up to 20 months, on the average. At entry into the study, galactose elimination capacity, aminopyrine breath test, and ICG clearance were measured. At the end of the study, 27 patients had died. Univariate analysis using the Kaplan-Meier method showed that both quantitative liver function tests (galactose elimination capacity: P less than 0.025; aminopyrine breath test: P less than 0.001; ICG clearance: P less than 0.005) and common clinical and biochemical data (encephalopathy: P less than 0.001; ascites: P less than 0.001; serum bilirubin: P less than 0.005; serum albumin: P less than 0.001; prothrombin index: P less than 0.05) were significant predictors of survival. To investigate whether quantitative liver function tests could contribute to a better definition of the prognosis, once Pugh score had already been taken into account, a multiple regression analysis according to the Cox model was performed. Pugh score and galactose elimination capacity resulted in the only independent prognostic covariates. From them a prognostic index was calculated, and the model was validated in an additional sample of 70 patients investigated according to the same protocol. The contribution GEC gave to the assessment of overall prognosis over that obtained using the Pugh score was slight, as estimated by the statistical parameters of the Cox's model, but was significant as assessed by a ROC curve analysis (P = 0.05). These data show that all quantitative liver function tests were predictors of survival in cirrhosis, and that the galactose elimination capacity added some new prognostic information to those already available using the Child-Turcotte-Pugh classification.
78例肝硬化患者被前瞻性随访,平均随访时间长达20个月。在研究开始时,测量了半乳糖清除能力、氨基比林呼气试验和吲哚菁绿清除率。研究结束时,27例患者死亡。使用Kaplan-Meier方法进行的单因素分析表明,定量肝功能试验(半乳糖清除能力:P<0.025;氨基比林呼气试验:P<0.001;吲哚菁绿清除率:P<0.005)以及常见的临床和生化数据(肝性脑病:P<0.001;腹水:P<0.001;血清胆红素:P<0.005;血清白蛋白:P<0.001;凝血酶原指数:P<0.05)均是生存的重要预测指标。为了研究在已经考虑Pugh评分的情况下,定量肝功能试验是否有助于更好地定义预后,根据Cox模型进行了多元回归分析。Pugh评分和半乳糖清除能力是仅有的独立预后协变量。据此计算了一个预后指数,并在按照相同方案进行研究的另外70例患者样本中对该模型进行了验证。根据Cox模型的统计参数估计,半乳糖清除能力对总体预后评估的贡献相对于使用Pugh评分所获得的贡献较小,但通过ROC曲线分析评估则具有显著性(P = 0.05)。这些数据表明,所有定量肝功能试验都是肝硬化患者生存的预测指标,并且半乳糖清除能力为已经通过Child-Turcotte-Pugh分类获得的预后信息增添了一些新的内容。